Treatment of behavioural symptoms and dementia in Parkinson's disease
Identifieur interne : 001399 ( Main/Exploration ); précédent : 001398; suivant : 001400Treatment of behavioural symptoms and dementia in Parkinson's disease
Auteurs : Hasmet A. Hanagasi ; Murat Emre [Turquie]Source :
- Fundamental & Clinical Pharmacology [ 0767-3981 ] ; 2005-04.
English descriptors
- KwdEn :
Abstract
Behavioural symptoms such as anxiety, depression and psychosis are common in Parkinson's disease (PD), and dementia occurs in about 90% of the patients. These symptoms can be more disabling than the motor dysfunction and they negatively impact quality of life, increase caregiver distress and are more frequently associated with nursing home placement. Depression can be treated with counselling and pharmacotherapy. Tricyclic antidepressants or selective serotonin reuptake inhibitors are widely used, but there is still need for controlled clinical trials. Management of psychosis in PD is complex and includes elimination of identifiable risk factors, reduction of polypharmacy and administration of atypical neuroleptics, which can alleviate psychotic symptoms without worsening motor functions. Clozapine is the best documented atypical neuroleptic shown to be effective against psychosis in PD patients. Cholinesterase inhibitors may prove additional benefit in psychotic PD patients. Recent evidence from small double‐blind and open‐label trials suggests that cholinesterase inhibitors may be effective in the treatment of dementia associated with PD.
Url:
DOI: 10.1111/j.1472-8206.2005.00317.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of behavioural symptoms and dementia in Parkinson's disease</title><author><name sortKey="Hanagasi, Hasmet A" sort="Hanagasi, Hasmet A" uniqKey="Hanagasi H" first="Hasmet A." last="Hanagasi">Hasmet A. Hanagasi</name></author><author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B1124346DA7DD08DE9100BC739BCBB890D9A3939</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1472-8206.2005.00317.x</idno><idno type="url">https://api.istex.fr/document/B1124346DA7DD08DE9100BC739BCBB890D9A3939/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000428</idno><idno type="wicri:Area/Main/Curation">000369</idno><idno type="wicri:Area/Main/Exploration">001399</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatment of behavioural symptoms and dementia in Parkinson's disease</title><author><name sortKey="Hanagasi, Hasmet A" sort="Hanagasi, Hasmet A" uniqKey="Hanagasi H" first="Hasmet A." last="Hanagasi">Hasmet A. Hanagasi</name></author><author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name><affiliation wicri:level="1"><country xml:lang="fr">Turquie</country><wicri:regionArea>Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, 34390 Capa/Istanbul</wicri:regionArea><wicri:noRegion>34390 Capa/Istanbul</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Fundamental & Clinical Pharmacology</title><idno type="ISSN">0767-3981</idno><idno type="eISSN">1472-8206</idno><imprint><publisher>Blackwell Science Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2005-04">2005-04</date><biblScope unit="volume">19</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="133">133</biblScope><biblScope unit="page" to="146">146</biblScope></imprint><idno type="ISSN">0767-3981</idno></series><idno type="istex">B1124346DA7DD08DE9100BC739BCBB890D9A3939</idno><idno type="DOI">10.1111/j.1472-8206.2005.00317.x</idno><idno type="ArticleID">FCP317</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0767-3981</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>anxiety</term><term>dementia</term><term>depression</term><term>psychosis</term><term>treatment</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Behavioural symptoms such as anxiety, depression and psychosis are common in Parkinson's disease (PD), and dementia occurs in about 90% of the patients. These symptoms can be more disabling than the motor dysfunction and they negatively impact quality of life, increase caregiver distress and are more frequently associated with nursing home placement. Depression can be treated with counselling and pharmacotherapy. Tricyclic antidepressants or selective serotonin reuptake inhibitors are widely used, but there is still need for controlled clinical trials. Management of psychosis in PD is complex and includes elimination of identifiable risk factors, reduction of polypharmacy and administration of atypical neuroleptics, which can alleviate psychotic symptoms without worsening motor functions. Clozapine is the best documented atypical neuroleptic shown to be effective against psychosis in PD patients. Cholinesterase inhibitors may prove additional benefit in psychotic PD patients. Recent evidence from small double‐blind and open‐label trials suggests that cholinesterase inhibitors may be effective in the treatment of dementia associated with PD.</div></front></TEI><affiliations><list><country><li>Turquie</li></country></list><tree><noCountry><name sortKey="Hanagasi, Hasmet A" sort="Hanagasi, Hasmet A" uniqKey="Hanagasi H" first="Hasmet A." last="Hanagasi">Hasmet A. Hanagasi</name></noCountry><country name="Turquie"><noRegion><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001399 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001399 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B1124346DA7DD08DE9100BC739BCBB890D9A3939
|texte= Treatment of behavioural symptoms and dementia in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |